StrIVe Wellness NJ(Mens Health-Testosterone Replacement Therapy, Peptide Therapy, IV Therapy, Medical Weight Loss)
StrIVe Wellness NJ(Mens Health-Testosterone Replacement Therapy, Peptide Therapy, IV Therapy, Medical Weight Loss) · 560 Springfield Avenue · Westfield, NJ 07090
5.0· 23 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
StrIVe Wellness Clinic is a wellness practice listed in Westfield, New Jersey, whose website also references Scotch Plains. The site describes testosterone replacement therapy, IV therapy and weight-loss programs, with a mission built on personalized care, education and support, and says one of its clinicians is a nurse practitioner with more than 10 years of oncology experience. Phone consultations are offered, per the site, and the listing also includes aesthetics. On Google the clinic holds a 5.0-star rating across 23 reviews dating back to 2025, with 1 in the past year, and reviewers most often mention the team's knowledge and the staff.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2025-10-07. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 23 Google reviews. Of the 20 reviews we analyzed, 20 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Knowledgeable, professional providers9 reviews
- Friendly, helpful staff8 reviews
- Feeling listened to3 reviews
- Clean, comfortable office3 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
Joycelyn B.★★★★★2025-10-07StrIVe Wellness NJ is incredible! Dr. Mercy is AMAZING — so quick and gentle with our shots, my partner and I were in and out in no time. She made the whole experience super easy. Plus, the office is gorgeous and so welcoming. Highly recommend it!
Arie T.★★★★★2025-09-11My IV therapy session was such a positive experience. Mercy was incredibly knowledgeable, kind, and made me feel completely at ease throughout the process. I truly appreciated how she explained everything clearly and shared thoughtful health tips that went beyond just the IV treatment. I left feeling refreshed, supported, and confident in her expertise. Highly recommend!
D S.★★★★★2025-06-22Highly recommend Strive for recovering after a night out. The practitioner was incredibly knowledgeable, kind, and helpful. Thanks for helping me feel like a human again!
Nana A.★★★★★2025-06-08I am back to feeling like myself again
daiane p.★★★★★2025-04-26Great place. So relaxing and the nurse is awesome. I actually took a nap while my IV was going in.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Westfield
ChillRx Cryotherapy
327 South Avenue West · Westfield, NJ 07090
4.7(244 Google reviews · 83 in past year)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs